FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307282693> ?p ?o ?g. }

• W4307282693 abstract "Epithelial‑mesenchymal transition (EMT) features are associated with pathological severity in the progression and metastasis of various cancer types, including bile duct cancer (BDC). Our previous study demonstrated that ursodeoxycholic acid (UDCA) blocked the EGFR‑MAPK signaling pathway and inhibited the invasion of BDC cells. The present study was performed to determine whether UDCA inhibits EMT and promotes the expression of E‑cadherin to inhibit the invasion and aggressiveness of BDC. In addition, the present study aimed to confirm that the primary mechanism of inhibition of EMT by UDCA is related to the EGFR axis. Human extrahepatic BDC cells were cultured. The effect of UDCA on cell proliferation was evaluated using MTT assays. A cell death ELISA kit was used to measure apoptosis, and western blot assays or immunofluorescence staining assays measured the expression levels of various target proteins. The mRNA expression of Slug and ZEB1 was evaluated via reverse transcription‑quantitative PCR. The invasiveness of BDC cells was estimated by invasion assays and western blot assays for focal adhesion kinase (FAK). UDCA inhibited the proliferation of BDC cells as effectively as gefitinib (an EGFR inhibitor), and the combination of UDCA and gefitinib revealed an additive effect on the proliferation of cells. UDCA and gefitinib induced apoptosis, and the combination of UDCA and gefitinib demonstrated an additive effect on apoptosis in BDC cells. UDCA restored the E‑cadherin expression inhibited by EGF and suppressed N‑cadherin expression increased by EGF as effectively as gefitinib. UDCA suppressed the Slug and ZEB1 mRNA expression induced by EGF in BDC cells. UDCA suppressed the invasiveness of BDC cells and FAK expression linked to the invasiveness of BDC. In conclusion, UDCA enhanced E‑cadherin expression and suppressed N‑cadherin expression through inhibition of the EGF‑EGFR axis, contributing to the inhibition of EMT and invasiveness in BDC cells. Therefore, UDCA may be applied as an adjuvant or palliative antineoplastic agent and as a therapeutic option to enhance the effect of other chemotherapeutics." @default.
• W4307282693 created "2022-10-31" @default.
• W4307282693 creator A5004620577 @default.
• W4307282693 creator A5006250732 @default.
• W4307282693 creator A5029758398 @default.
• W4307282693 creator A5031686790 @default.
• W4307282693 creator A5054445430 @default.
• W4307282693 creator A5058376995 @default.
• W4307282693 date "2022-10-26" @default.
• W4307282693 modified "2023-10-14" @default.
• W4307282693 title "Ursodeoxycholic acid inhibits epithelial‑mesenchymal transition, suppressing invasiveness of bile duct cancer cells: An <i>in vitro</i> study" @default.
• W4307282693 cites W118213103 @default.
• W4307282693 cites W1711861384 @default.
• W4307282693 cites W1964081206 @default.
• W4307282693 cites W1964321121 @default.
• W4307282693 cites W1973701648 @default.
• W4307282693 cites W1979379023 @default.
• W4307282693 cites W1990269755 @default.
• W4307282693 cites W1991256030 @default.
• W4307282693 cites W1995242599 @default.
• W4307282693 cites W2005496035 @default.
• W4307282693 cites W2005901103 @default.
• W4307282693 cites W2007769088 @default.
• W4307282693 cites W2007848898 @default.
• W4307282693 cites W2012347139 @default.
• W4307282693 cites W2016360721 @default.
• W4307282693 cites W2018149997 @default.
• W4307282693 cites W2020014734 @default.
• W4307282693 cites W2033143569 @default.
• W4307282693 cites W2034060355 @default.
• W4307282693 cites W2036891904 @default.
• W4307282693 cites W2037041091 @default.
• W4307282693 cites W2039214381 @default.
• W4307282693 cites W2040366189 @default.
• W4307282693 cites W2043197358 @default.
• W4307282693 cites W2054870962 @default.
• W4307282693 cites W2055247678 @default.
• W4307282693 cites W2055318932 @default.
• W4307282693 cites W2059650429 @default.
• W4307282693 cites W2063515380 @default.
• W4307282693 cites W2077403258 @default.
• W4307282693 cites W2079630625 @default.
• W4307282693 cites W2082827206 @default.
• W4307282693 cites W2085312694 @default.
• W4307282693 cites W2089209606 @default.
• W4307282693 cites W2090569390 @default.
• W4307282693 cites W2093034235 @default.
• W4307282693 cites W2104546896 @default.
• W4307282693 cites W2104933407 @default.
• W4307282693 cites W2105772211 @default.
• W4307282693 cites W2107277218 @default.
• W4307282693 cites W2123185404 @default.
• W4307282693 cites W2130699828 @default.
• W4307282693 cites W2139819066 @default.
• W4307282693 cites W2147982661 @default.
• W4307282693 cites W2152006092 @default.
• W4307282693 cites W2154994056 @default.
• W4307282693 cites W2156359059 @default.
• W4307282693 cites W2158114950 @default.
• W4307282693 cites W2163732518 @default.
• W4307282693 cites W2192080449 @default.
• W4307282693 cites W2263089384 @default.
• W4307282693 cites W2413507055 @default.
• W4307282693 cites W2560087117 @default.
• W4307282693 cites W2564277174 @default.
• W4307282693 cites W2947645208 @default.
• W4307282693 cites W2949922878 @default.
• W4307282693 cites W3194365726 @default.
• W4307282693 cites W4231946034 @default.
• W4307282693 doi "https://doi.org/10.3892/ol.2022.13568" @default.
• W4307282693 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36420069" @default.
• W4307282693 hasPublicationYear "2022" @default.
• W4307282693 type Work @default.
• W4307282693 citedByCount "0" @default.
• W4307282693 crossrefType "journal-article" @default.
• W4307282693 hasAuthorship W4307282693A5004620577 @default.
• W4307282693 hasAuthorship W4307282693A5006250732 @default.
• W4307282693 hasAuthorship W4307282693A5029758398 @default.
• W4307282693 hasAuthorship W4307282693A5031686790 @default.
• W4307282693 hasAuthorship W4307282693A5054445430 @default.
• W4307282693 hasAuthorship W4307282693A5058376995 @default.
• W4307282693 hasBestOaLocation W43072826931 @default.
• W4307282693 hasConcept C121608353 @default.
• W4307282693 hasConcept C185592680 @default.
• W4307282693 hasConcept C190283241 @default.
• W4307282693 hasConcept C2779013556 @default.
• W4307282693 hasConcept C2779438470 @default.
• W4307282693 hasConcept C2780580887 @default.
• W4307282693 hasConcept C2780783641 @default.
• W4307282693 hasConcept C2780965833 @default.
• W4307282693 hasConcept C2781018059 @default.
• W4307282693 hasConcept C29537977 @default.
• W4307282693 hasConcept C502942594 @default.
• W4307282693 hasConcept C54355233 @default.
• W4307282693 hasConcept C55493867 @default.
• W4307282693 hasConcept C62112901 @default.
• W4307282693 hasConcept C76419328 @default.
• W4307282693 hasConcept C86803240 @default.
• W4307282693 hasConceptScore W4307282693C121608353 @default.
• W4307282693 hasConceptScore W4307282693C185592680 @default.

• next